scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037861544 |
P356 | DOI | 10.1186/2001-1326-3-24 |
P932 | PMC publication ID | 4106911 |
P698 | PubMed publication ID | 25097727 |
P5875 | ResearchGate publication ID | 264537934 |
P50 | author | Lauren S Sherman | Q59695118 |
P2093 | author name string | Pranela Rameshwar | |
Katherine Liu | |||
Alexander Aleynik | |||
Yuriy A Gubenko | |||
Kevin M Gernavage | |||
Yasmine Sh Mourad | |||
P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides | Q22242269 | ||
New insights into brain BDNF function in normal aging and Alzheimer disease | Q22252335 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Particle-mediated delivery of cytokines for immunotherapy | Q26997993 | ||
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | Q27824850 | ||
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA | Q27860813 | ||
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) | Q28175138 | ||
Exosomes: a common pathway for a specialized function | Q28254986 | ||
Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier | Q28257034 | ||
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7 | Q28303603 | ||
Diversity of raft-like domains in late endosomes | Q28469178 | ||
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease | Q29547175 | ||
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors | Q30435946 | ||
Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview | Q30442623 | ||
Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network | Q30496591 | ||
Development of neuropeptide drugs that cross the blood-brain barrier | Q33569277 | ||
Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial | Q33605719 | ||
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. | Q33819663 | ||
microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network. | Q33883240 | ||
Drug delivery to brain via the blood-brain barrier | Q33963752 | ||
Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 | ||
Global changes of mRNA expression reveals an increased activity of the interferon-induced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells | Q34112784 | ||
Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents. | Q34171102 | ||
Stem cells as therapeutic vehicles for the treatment of high-grade gliomas | Q34240433 | ||
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. | Q34319936 | ||
Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature | Q34590239 | ||
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. | Q34733023 | ||
Getting into the brain: approaches to enhance brain drug delivery | Q34897833 | ||
Exosomes as immunotheranostic nanoparticles. | Q35174460 | ||
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity | Q39776996 | ||
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model | Q39869090 | ||
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal | Q39916475 | ||
Focused ultrasound microbubble destruction-mediated changes in blood-brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging | Q39935746 | ||
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene | Q40141485 | ||
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. | Q40195961 | ||
Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix | Q40617695 | ||
Separation and characterization of late endosomal membrane domains | Q40725060 | ||
Gene therapy of multiple sclerosis using interferon β-secreting human bone marrow mesenchymal stem cells | Q40726859 | ||
Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. | Q42218017 | ||
Use of memantine to treat Alzheimer's disease | Q42880780 | ||
Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice | Q43636678 | ||
Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry. | Q44346739 | ||
Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study | Q44572388 | ||
Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease | Q45298203 | ||
Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas | Q45870836 | ||
Exosomes are released by cultured cortical neurones. | Q46918951 | ||
Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model | Q47406084 | ||
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling | Q47620825 | ||
Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome | Q48198558 | ||
Molecular Trojan horses for blood-brain barrier drug delivery. | Q48306206 | ||
Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons. | Q48436062 | ||
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease | Q48820847 | ||
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain. | Q53435365 | ||
Mesenchymal Stem Cell-Conditioned Medium Triggers Neuroinflammation and Reactive Species Generation in Organotypic Cultures of Rat Hippocampus | Q60349719 | ||
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
In search of the in vivo identity of mesenchymal stem cells | Q81485769 | ||
microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis | Q35185340 | ||
The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier | Q35585191 | ||
Lipids as targeting signals: lipid rafts and intracellular trafficking. | Q35696773 | ||
Identification and proteomic profiling of exosomes in human cerebrospinal fluid | Q35744824 | ||
Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems | Q36089997 | ||
Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis | Q36130979 | ||
Brain meets body: the blood-brain barrier as an endocrine interface | Q36177451 | ||
The art of gene therapy for glioma: a review of the challenging road to the bedside | Q36527593 | ||
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal | Q37016591 | ||
Remyelination of the spinal cord following intravenous delivery of bone marrow cells | Q37020042 | ||
Therapeutic nanomedicine for brain cancer | Q37338427 | ||
Stem cell-based cell therapy in neurological diseases: a review | Q37419268 | ||
Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting | Q37514889 | ||
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases | Q37576225 | ||
Oncogenic EGFR signaling networks in glioma | Q37593841 | ||
Tumor-derived exosomes: A message delivery system for tumor progression. | Q37716749 | ||
Intrathecal therapy for cancer and non-cancer pain. | Q37876696 | ||
MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme | Q37897499 | ||
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy | Q37978315 | ||
Current thoughts on the therapeutic potential of stem cell | Q38011631 | ||
Drug delivery to the brain via the blood-brain barrier: a review of the literature and some recent patent disclosures | Q38029666 | ||
Stem cell based glioblastoma gene therapy | Q38031961 | ||
Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases | Q38033935 | ||
Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. | Q38040409 | ||
Receptor-mediated endocytosis and brain delivery of therapeutic biologics | Q38120524 | ||
From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? | Q38133556 | ||
Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. | Q38184764 | ||
Recent advances in delivery through the blood-brain barrier | Q38200122 | ||
MiRNA-451 plays a role as tumor suppressor in human glioma cells | Q38341125 | ||
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. | Q38593312 | ||
Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma | Q38961512 | ||
Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma | Q39512141 | ||
miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β | Q39646428 | ||
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. | Q39725116 | ||
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status | Q39756064 | ||
P304 | page(s) | 24 | |
P577 | publication date | 2014-07-19 | |
P1433 | published in | Clinical and translational medicine | Q27724586 |
P1476 | title | Stem cell delivery of therapies for brain disorders | |
P478 | volume | 3 |
Q38664590 | A discussion on adult mesenchymal stem cells for drug delivery: pros and cons |
Q28067160 | Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases |
Q47096921 | Efficacy of Two Delivery Routes for Transplanting Human Neural Progenitor Cells (NPCs) Into the Spastic Han-Wistar Rat, a Model of Ataxia |
Q104617814 | Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo |
Q42362461 | Gene mutation-based and specific therapies in precision medicine |
Q47554530 | Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review). |
Q36939755 | Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. |
Q41688586 | Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative Strategies |
Q42368133 | Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal? |
Q49823898 | Hypoxia-Preconditioned Human Umbilical Vein Endothelial Cells Protect Against Neurovascular Damage After Hypoxic Ischemia in Neonatal Brain. |
Q90605371 | In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies |
Q92816537 | Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease |
Q90168903 | Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration |
Q47280331 | Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington's Disease |
Q39725955 | Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival |
Q42705650 | Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies |
Q38938919 | Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials |
Q26778682 | Stem cell transplantation therapy in Parkinson's disease |
Q55400539 | Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. |
Q38919180 | Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level |
Q48244063 | The role of nanomaterials in cell delivery systems. |
Q64991845 | Wharton's Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study. |